Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Identifying the neurodevelopmental and psychiatric signatures of genomic disorders associated with intellectual disability: a machine learning approach

N. Donnelly, A. Cunningham, SM. Salas, M. Bracher-Smith, S. Chawner, J. Stochl, T. Ford, FL. Raymond, V. Escott-Price, MBM. van den Bree

. 2023 ; 14 (1) : 19. [pub] 20230523

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem, Research Support, N.I.H., Extramural

Perzistentní odkaz   https://www.medvik.cz/link/bmc23011391

Grantová podpora
MR/L011166/1 Medical Research Council - United Kingdom
U01 MH119738 NIMH NIH HHS - United States
Department of Health - United Kingdom
MR/T033045/1 Medical Research Council - United Kingdom
MR/N022572/1 Medical Research Council - United Kingdom

BACKGROUND: Genomic conditions can be associated with developmental delay, intellectual disability, autism spectrum disorder, and physical and mental health symptoms. They are individually rare and highly variable in presentation, which limits the use of standard clinical guidelines for diagnosis and treatment. A simple screening tool to identify young people with genomic conditions associated with neurodevelopmental disorders (ND-GCs) who could benefit from further support would be of considerable value. We used machine learning approaches to address this question. METHOD: A total of 493 individuals were included: 389 with a ND-GC, mean age = 9.01, 66% male) and 104 siblings without known genomic conditions (controls, mean age = 10.23, 53% male). Primary carers completed assessments of behavioural, neurodevelopmental and psychiatric symptoms and physical health and development. Machine learning techniques (penalised logistic regression, random forests, support vector machines and artificial neural networks) were used to develop classifiers of ND-GC status and identified limited sets of variables that gave the best classification performance. Exploratory graph analysis was used to understand associations within the final variable set. RESULTS: All machine learning methods identified variable sets giving high classification accuracy (AUROC between 0.883 and 0.915). We identified a subset of 30 variables best discriminating between individuals with ND-GCs and controls which formed 5 dimensions: conduct, separation anxiety, situational anxiety, communication and motor development. LIMITATIONS: This study used cross-sectional data from a cohort study which was imbalanced with respect to ND-GC status. Our model requires validation in independent datasets and with longitudinal follow-up data for validation before clinical application. CONCLUSIONS: In this study, we developed models that identified a compact set of psychiatric and physical health measures that differentiate individuals with a ND-GC from controls and highlight higher-order structure within these measures. This work is a step towards developing a screening instrument to identify young people with ND-GCs who might benefit from further specialist assessment.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23011391
003      
CZ-PrNML
005      
20230801133022.0
007      
ta
008      
230718s2023 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s13229-023-00549-2 $2 doi
035    __
$a (PubMed)37221545
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Donnelly, Nicholas $u Centre for Academic Mental Health, Population Health Sciences, University of Bristol, Bristol, UK $u MRC Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK $1 https://orcid.org/0000000322348545
245    10
$a Identifying the neurodevelopmental and psychiatric signatures of genomic disorders associated with intellectual disability: a machine learning approach / $c N. Donnelly, A. Cunningham, SM. Salas, M. Bracher-Smith, S. Chawner, J. Stochl, T. Ford, FL. Raymond, V. Escott-Price, MBM. van den Bree
520    9_
$a BACKGROUND: Genomic conditions can be associated with developmental delay, intellectual disability, autism spectrum disorder, and physical and mental health symptoms. They are individually rare and highly variable in presentation, which limits the use of standard clinical guidelines for diagnosis and treatment. A simple screening tool to identify young people with genomic conditions associated with neurodevelopmental disorders (ND-GCs) who could benefit from further support would be of considerable value. We used machine learning approaches to address this question. METHOD: A total of 493 individuals were included: 389 with a ND-GC, mean age = 9.01, 66% male) and 104 siblings without known genomic conditions (controls, mean age = 10.23, 53% male). Primary carers completed assessments of behavioural, neurodevelopmental and psychiatric symptoms and physical health and development. Machine learning techniques (penalised logistic regression, random forests, support vector machines and artificial neural networks) were used to develop classifiers of ND-GC status and identified limited sets of variables that gave the best classification performance. Exploratory graph analysis was used to understand associations within the final variable set. RESULTS: All machine learning methods identified variable sets giving high classification accuracy (AUROC between 0.883 and 0.915). We identified a subset of 30 variables best discriminating between individuals with ND-GCs and controls which formed 5 dimensions: conduct, separation anxiety, situational anxiety, communication and motor development. LIMITATIONS: This study used cross-sectional data from a cohort study which was imbalanced with respect to ND-GC status. Our model requires validation in independent datasets and with longitudinal follow-up data for validation before clinical application. CONCLUSIONS: In this study, we developed models that identified a compact set of psychiatric and physical health measures that differentiate individuals with a ND-GC from controls and highlight higher-order structure within these measures. This work is a step towards developing a screening instrument to identify young people with ND-GCs who might benefit from further specialist assessment.
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé $7 D006801
650    _2
$a mladiství $7 D000293
650    _2
$a dítě $7 D002648
650    _2
$a ženské pohlaví $7 D005260
650    12
$a mentální retardace $7 D008607
650    12
$a poruchy autistického spektra $7 D000067877
650    _2
$a kohortové studie $7 D015331
650    _2
$a průřezové studie $7 D003430
650    _2
$a genomika $7 D023281
650    _2
$a strojové učení $7 D000069550
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
700    1_
$a Cunningham, Adam $u Division of Psychological Medicine and Clinical Neurosciences, Centre for Neuropsychiatric Genetics and Genomics, Institute of Psychological Medicine and Clinical Neurosciences, Cardiff University School of Medicine, Hadyn Ellis Building, Maindy Road, Cathays, Cardiff, CF24 4HQ, UK $1 https://orcid.org/0000000297917813
700    1_
$a Salas, Sergio Marco $u Division of Psychological Medicine and Clinical Neurosciences, Centre for Neuropsychiatric Genetics and Genomics, Institute of Psychological Medicine and Clinical Neurosciences, Cardiff University School of Medicine, Hadyn Ellis Building, Maindy Road, Cathays, Cardiff, CF24 4HQ, UK $1 https://orcid.org/0000000246360322
700    1_
$a Bracher-Smith, Matthew $u Division of Psychological Medicine and Clinical Neurosciences, Centre for Neuropsychiatric Genetics and Genomics, Institute of Psychological Medicine and Clinical Neurosciences, Cardiff University School of Medicine, Hadyn Ellis Building, Maindy Road, Cathays, Cardiff, CF24 4HQ, UK $1 https://orcid.org/0000000205316309
700    1_
$a Chawner, Samuel $u Division of Psychological Medicine and Clinical Neurosciences, Centre for Neuropsychiatric Genetics and Genomics, Institute of Psychological Medicine and Clinical Neurosciences, Cardiff University School of Medicine, Hadyn Ellis Building, Maindy Road, Cathays, Cardiff, CF24 4HQ, UK $1 https://orcid.org/0000000225902874
700    1_
$a Stochl, Jan $u Department of Psychiatry, University of Cambridge, Cambridge, UK $u Department of Kinanthropology, Charles University, Prague, Czechia $1 https://orcid.org/0000000296939930 $7 jx20090130018
700    1_
$a Ford, Tamsin $u Department of Psychiatry, University of Cambridge, Cambridge, UK $1 https://orcid.org/0000000152954904
700    1_
$a Raymond, F Lucy $u Department of Medical Genetics, University of Cambridge, Cambridge, UK $1 https://orcid.org/0000000326523355
700    1_
$a Escott-Price, Valentina $u Division of Psychological Medicine and Clinical Neurosciences, Centre for Neuropsychiatric Genetics and Genomics, Institute of Psychological Medicine and Clinical Neurosciences, Cardiff University School of Medicine, Hadyn Ellis Building, Maindy Road, Cathays, Cardiff, CF24 4HQ, UK $1 https://orcid.org/0000000317845483
700    1_
$a van den Bree, Marianne B M $u Division of Psychological Medicine and Clinical Neurosciences, Centre for Neuropsychiatric Genetics and Genomics, Institute of Psychological Medicine and Clinical Neurosciences, Cardiff University School of Medicine, Hadyn Ellis Building, Maindy Road, Cathays, Cardiff, CF24 4HQ, UK. vandenBreeMB@cardiff.ac.uk $1 https://orcid.org/0000000244263254
773    0_
$w MED00207607 $t Molecular autism $x 2040-2392 $g Roč. 14, č. 1 (2023), s. 19
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37221545 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230718 $b ABA008
991    __
$a 20230801133019 $b ABA008
999    __
$a ok $b bmc $g 1963672 $s 1197656
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 14 $c 1 $d 19 $e 20230523 $i 2040-2392 $m Molecular autism $n Mol Autism $x MED00207607
GRA    __
$a MR/L011166/1 $p Medical Research Council $2 United Kingdom
GRA    __
$a U01 MH119738 $p NIMH NIH HHS $2 United States
GRA    __
$p Department of Health $2 United Kingdom
GRA    __
$a MR/T033045/1 $p Medical Research Council $2 United Kingdom
GRA    __
$a MR/N022572/1 $p Medical Research Council $2 United Kingdom
LZP    __
$a Pubmed-20230718

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...